Skip to content
Riskpilot
← Back to search
Sign in
Get full access
Abarceo Pharma AB
AB
Active
Org 5591397160
Per Albin Hanssons Väg 41, 214 32
Malmö
Research and experimental development on natural sciences and engineering
·
NACE 7210
Est. 2017 · 8 years old
5 employees
Monitor
Share
Sweden
/
Companies
/
Research and experimental development on natural sciences and engineering
/
Abarceo Pharma AB
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
SEK millions
0M
1M
3M
4M
6M
0M
2020
0M
2021
0M
2022
0M
2023
5M
2024
EBITDA
SEK millions
0M
-5M
-10M
-15M
-20M
-1M
2020
-9M
-800%
2021
-16M
-78%
2022
-16M
0%
2023
-7M
+56%
2024
Income statement
SEK thousands
Item
2020
2021
2022
2023
2024
Revenue
0
0
0
0
4 889
Staff expenses
—
—
—
—
—
EBITDA
−1 174
−8 899
−15 521
−16 441
−6 656
Depreciation & amort.
−0
−7 221
−66
−98
−98
EBIT
−1 174
−16 120
−15 587
−16 539
−6 754
Net financials
−2
−2
−1
43
1
Profit before tax
−1 176
−16 122
−15 588
−16 496
−6 754
Tax
−0
−0
−0
−0
−0
Net profit
−1 176
−16 122
−15 588
−16 496
−6 754
Balance sheet
SEK thousands
Item
2020
2021
2022
2023
2024
Total assets
8 164
12 987
17 106
4 888
5 948
Equity
4 907
10 909
−4 624
−11 878
−18 631
Long-term debt
1 600
0
14 172
10 423
0
Short-term debt
1 656
2 077
7 558
6 343
24 580
Total debt
3 256
2 077
21 730
16 766
24 580
Financial ratios
5-year trend
EBITDA margin
-136.1%
This company
15.8%
Market median
-961% vs market
2020
2024
Equity ratio
-313.2%
This company
38.2%
Market median
-920% vs market
2020
2024
Return on equity
-675400000.0%
This company
18.4%
Market median
-3670652274% vs market
2020
2024
Net profit margin
-138.1%
This company
8.1%
Market median
-1805% vs market
2020
2024
Asset turnover
0.82×
This company
1.12×
Market median
+27% vs market
2020
2024
Debt / equity
1.32×
This company
0.62×
Market median
-113% vs market
2020
2024
Annual reports & filings
Annual report 2024
Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
View
PDF
Annual report 2020
Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
View
PDF
More on Abarceo Pharma AB
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
